Charles River to Buy Frontage Operations for Up to $545 Million Cash
Charles River Laboratories agreed to acquire Frontage Holdings' bioanalysis and DMPK operations for approximately $470 million in cash, subject to conditions.
HONG KONG (dpa-AFX) - Charles River Laboratories International, Inc. (CRL) announced Monday that it has entered into definitive agreements to acquire Hong Kong-based Frontage Holdings Corp.'s bioanalysis and DMPK operations in Exton, Pennsylvania for approximately $470 million in cash, subject to c…